Before the 'reefer-endum' arrives, the country's legalization bill could still benefit from a few edits, say leading addiction researchers.
The study found that these claims were more common in US states that listed opioid use disorder as a qualifying condition for medical cannabis.
To help decide what to do with the impounded products, state authorities are welcoming input from the public until July 15.
Product testing conducted by the US Food and Drug Administration (FDA) has found that many CBD-infused products on sale in the United States are mislabeled, containing vastly differing amounts of CBD than advertised on the product packaging.
The new rule was initially meant to take effect on April 1, but delays were made amid the coronavirus pandemic.
The new study could help determine how brain network patterns may change once consumers reduce their cannabis intake.
The cannabis and hemp testing company Kaycha Labs has become the first business in Florida to be awarded the state Department of Health’s certified marijuana testing laboratory status.